XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
  Hemophilia
  Anaemia
  Polycythemia
  Thalassemias
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Haematology Channel
subscribe to Haematology newsletter

Latest Research : Haematology

   DISCUSS   |   EMAIL   |   PRINT
Anaemia Associated With Higher Risk of Geriatric Death
Oct 25, 2005, 05:22, Reviewed by: Dr.

"In conclusion, a lower hemoglobin concentration was independently associated with mortality in this elderly cohort. The bottom hemoglobin quintile defined a larger group at risk than anemia status based on WHO criteria. Future areas of investigation should determine the optimal hemoglobin value that defines an abnormal concentration in elderly individuals, study the causes of low hemoglobin concentrations in elderly individuals and how these relate differentially to outcomes, evaluate the causes of increased mortality in individuals with low and high hemoglobin concentrations, and assess whether treatment of low hemoglobin in the general population reduces mortality."

 
Elderly people with the lowest and highest hemoglobin concentrations (the component of red blood cells that carries oxygen) are at increased risk of death, according to a study in the October 24 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.

Increasing evidence indicates that anemia is common in the elderly population, but few studies have assessed the association of anemia with clinical outcomes, such as illness and death, according to background information in the article. Anemia is defined by the World Health Organization (WHO) as a hemoglobin concentration of less than 12 g/dL (grams per one tenth liter) for women and less than 13 g/dL for men.

Neil A. Zakai, M.D., of the University of Vermont College of Medicine, Burlington, compared the association of hemoglobin concentration and anemia status with subsequent death over the course of eleven years in elderly adults living in four U.S. communities. Hemoglobin concentrations were determined for participants recruited between 1989 and 1993. Participants were contacted biannually; telephone and clinic examinations were conducted alternately. Deaths were reviewed and classified as cardiovascular or noncardiovascular. Complete follow-up was available through June 2001 for this analysis.

Hemoglobin concentration was analyzed in two ways: by dividing the participants' baseline hemoglobin into five equal levels and by the WHO criteria for anemia. Based on the WHO criteria for anemia, 498 individuals were anemic on enrollment (8.5 percent of the 5,797 included in the analysis), the researchers report. The hemoglobin concentration for the 1,205 individuals in the lowest fifth was higher than the WHO criteria for anemia, and 41.3 percent of these 1,205 people did qualify as anemic by WHO standards.

"In this elderly cohort, the prevalence of anemia was 7.0 percent among white and 17.6 percent among black individuals," the authors write. "After 11.2 years of follow-up, lower hemoglobin concentrations were associated with increased mortality risk, independent of many potentially confounding factors. The magnitude of this association was similar whether the lowest quintile [fifth] of hemoglobin or the WHO criteria for anemia was used; however, the number of participants was much larger when considering the lowest quintile of hemoglobin concentration." Another finding of the study was that there was also elevated mortality among those in the highest hemoglobin quintile, even after extensive adjustment for other factors.

"In conclusion, a lower hemoglobin concentration was independently associated with mortality in this elderly cohort," the authors write. "The bottom hemoglobin quintile defined a larger group at risk than anemia status based on WHO criteria. Future areas of investigation should determine the optimal hemoglobin value that defines an abnormal concentration in elderly individuals, study the causes of low hemoglobin concentrations in elderly individuals and how these relate differentially to outcomes, evaluate the causes of increased mortality in individuals with low and high hemoglobin concentrations, and assess whether treatment of low hemoglobin in the general population reduces mortality."

In an accompanying editorial, Jerry L. Spivak, M.D., of The Johns Hopkins University School of Medicine, Baltimore, Md., writes, "The four articles in this issue of the Archives usefully highlight and advance our conceptions of the cause of anemia in the elderly and anemia's health-related impact. Anemia, of course, is always the consequence of another disorder, and correction of the underlying disorder is the most effective means of alleviating the anemia. However, anemia in the majority of the elderly is caused by conditions such as chronic renal insufficiency, chronic inflammation, cancer, or bone marrow failure, some of which are actually an aftermath of the aging process and most of which defy correction. It is now also well established that anemia frequently exacerbates the illness causing it, while having its own independent adverse effects."

"What remains to be determined is whether pharmacologic correction of anemia can slow disease progression, reduce morbidity [illness], improve quality of life, and prolong survival, and whether there is a favorable cost-benefit ratio to society for such improvements," Dr. Spivak continues. "Recent failed attempts to answer these questions in the setting of renal failure or cancer indicate that this will not be an easy task, but the prospect of a doubling in the number of elderly persons over the next 25 years indicates that it is a task that cannot be ignored or deferred."
 

- October 24 issue of the Archives of Internal Medicine
 

Arch Intern Med. 2005;165:2214-2220

 
Subscribe to Haematology Newsletter
E-mail Address:

 

This research was supported by contracts from the National Heart, Lung, and Blood Institute, Bethesda, Md. Dr. Cushman has received research funding in the form of a subcontract with the University of Alabama funded by Amgen; the project is not related to this article.

Related Haematology News

High-dose Calcitriol (DN-101) with Docetaxel Reduced Thrombosis
Blood-compatible nanoscale materials possible using heparin
Potential of HOXB4 and Hematopoietic Stem Cell Expansion
Deferasirox may revolutionize the way chronic iron overload is treated
Alpha-Thalassemia and Protection from Malaria
New research links αIIbβ3 to Glanzmann thrombasthenia
Hemophilia a silent killer
MBD2 Protein mediates silencing of the fetal gamma-globin gene through DNA methylation
JAK2 Mutation in blood stem cells provides clues to polycythemia vera
Urinary infection could cause deep vein thrombosis


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us